SCYNEXIS, Inc. (SCYX) — Stock Score Summary

SCYNEXIS, Inc. (SCYX) has a MoatMap StockRank of 31/100 based on Quality (46/100), Value (35/100), and Momentum (37/100) factor scores. The current signal is SELL. Scynexis is a micro-cap biotech company with high binary clinical trial risk. It lacks the manufacturing scale, commercial footprint, and recurring cash flows required for our concentrated quality portfolio.

SCYNEXIS, Inc. is a biotechnology company focused on developing and commercializing novel therapies to overcome and prevent difficult-to-treat infections. The company's primary asset is ibrexafungerp, a first-in-class oral antifungal agent that serves as a strong competitive moat against traditional, resistant fungal strains. It operates as a specialty pharmaceutical player targeting the high-unmet-need anti-infective market.

Key Financial Metrics

Price$4.36
Market Cap$58M
P/E (Forward)-1.94
Price/Book7.33
Return on Equity-53.4%
Return on Invested Capital-15.8%
Debt/Equity4.99
Gross Margin100.0%
Operating Margin-120.0%
Free Cash Flow$3M

SCYNEXIS, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is SCYNEXIS, Inc.’s (SCYX) StockRank?
MoatMap’s StockRank for SCYNEXIS, Inc. (SCYX) is 31/100, with a Sell signal. It is a composite of Quality (46), Value (35), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does SCYNEXIS, Inc. have an economic moat?
SCYNEXIS, Inc. (SCYX) has a Quality factor score of 46/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is SCYNEXIS, Inc. a buy, hold, or sell?
MoatMap’s current signal for SCYNEXIS, Inc. (SCYX) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is SCYNEXIS, Inc. in?
SCYNEXIS, Inc. (SCYX) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksSCYX deep dive reportAI ChampionsHow we score stocksSense-check another stock